Hjem › Amyloidose › Massachusetts
Amyloidose kliniske forsøg i Massachusetts
11 studier for Amyloidose søger deltagere på steder i Massachusetts.
Byer i Massachusetts
Officiel studietekst (engelsk)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Boston
- Research Site, Boston
- Research Site, Boston
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Boston
- Clinical Trial Site, Boston
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 16. sep. 2026 · NCT07052903TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
- Clinical Trial Site, Boston
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 15. sep. 2026 · NCT07223203DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, Boston
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07358078Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
- Massachusetts General Hospital, Boston
Rekrutterer
Alder 65 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT05577819Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
- Boston University (BU) School of Medicine, Boston
RekruttererFase 3
Alder 18 til 75 · Alle køn · Opdateret 4. aug. 2026 · NCT06563895[64Cu]FBP8 PET for Early Detection of Intracardiac Thrombus in Amyloid Cardiomyopathy
- Brigham and Women's Hospital, Boston
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 21. jul. 2026 · NCT07560306A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, Boston
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT07081646A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
- Boston Medical Center /ID# 255066, Boston
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT06158854MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- Brigham and Women's Hospital, Boston
- Boston University School of Medicine, Boston
RekruttererFase 3
Alder 18 til 90 · Alle køn · Opdateret 27. mar. 2026 · NCT06128629Molecular Imaging of Primary Amyloid Cardiomyopathy
- Brigham and Womens' Hospital, Boston
Rekrutterer
Alder 18 til 99 · Alle køn · Opdateret 14. nov. 2025 · NCT02641145Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.